Cardiovascular Effects of Empagliflozine

Clinical trial NCT02918591 · UNKNOWN

Trial details

NCT number: NCT02918591
Sponsor: Tel Aviv University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2017-11-01
Primary completion: 2018-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.